Merck KGaA Stock

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 11:35:14 2024-04-23 am EDT 5-day change 1st Jan Change
153.6 EUR +4.03% Intraday chart for Merck KGaA +1.69% +6.63%
Sales 2024 * 21.25B 22.74B Sales 2025 * 22.5B 24.08B Capitalization 66.8B 71.5B
Net income 2024 * 2.97B 3.18B Net income 2025 * 3.48B 3.72B EV / Sales 2024 * 3.46 x
Net Debt 2024 * 6.79B 7.27B Net Debt 2025 * 4.83B 5.17B EV / Sales 2025 * 3.18 x
P/E ratio 2024 *
22.5 x
P/E ratio 2025 *
19.1 x
Employees 62,908
Yield 2024 *
1.5%
Yield 2025 *
1.57%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.03%
1 week+0.95%
Current month-6.08%
1 month-5.04%
3 months+3.85%
6 months+3.26%
Current year+6.63%
More quotes
1 week
142.70
Extreme 142.7
154.95
1 month
142.70
Extreme 142.7
164.85
Current year
140.50
Extreme 140.5
164.85
1 year
134.30
Extreme 134.3
172.40
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
59.18
Extreme 59.175
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 53 19-04-25
Members of the board TitleAgeSince
Director/Board Member 75 14-05-08
Director/Board Member - -
Chairman 67 19-04-25
More insiders
Date Price Change Volume
24-04-23 153.6 +4.03% 503,255
24-04-22 147.7 +1.16% 214,993
24-04-19 146 -0.51% 353,173
24-04-18 146.8 -0.31% 511,371
24-04-17 147.2 -2.58% 370,848

Delayed Quote Xetra, April 23, 2024 at 11:35 am EDT

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
153.6 EUR
Average target price
182 EUR
Spread / Average Target
+18.45%
Consensus